Penumbra PEN 深 沪
等待开盘 09-11 09:30:00 美东时间
317.78
-1.790
-0.56%
华盛通- 最 高319.38
- 今 开319.38
- 成交量 14.13万股
- 最 低 317.62
- 昨 收 319.57
- 总市值 125.17亿
- 52周最高 362.41
- 市盈率 静 70.27
- 换手率 0.36%
- 52周最低 221.26
- 委 比 42.86%
- 总股本 3938.94万
- 历史最高 362.41
- 量 比 0.54
- 振 幅 0.55%
- 历史最低 35.315
- 每 手 1
- 风险率 31.12%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多10场并购后，裁员12049人
来源：器械之家，未经授权不得转载，且24小时后方可转载 并购后开展大规模裁员，似乎已成为行业惯例。 器械之家统计，今年以来已有波科、卡尔·史托斯、赛诺菲、甲...
08-29 19:32
Incuvate Files Patent Infringement Lawsuit Against Penumbra
Incuvate, LLC today announced that it has filed a patent-infringement lawsuit against Penumbra, Inc. in the U.S. District Court for the Northern District of California. The lawsuit, filed August 19, 2026, alleges that Penumbra’s recently launched THUNDERBOLT™ Neurovascular Thrombectomy System and re...
08-26 03:39
华盛早报 | 伯克希尔、段永平、李录、索罗斯等Q2持仓曝光！美政府抵制苹果采用中国芯片；英伟达缩减OpenAI数据中心担保规模逾5成
伯克希尔、段永平、李录、索罗斯等Q2持仓曝光！特朗普政府施压苹果：禁用中国存储芯片；降幅超5成！英伟达缩减对OpenAI数据中心担保规模>>
08-17 08:19
Penumbra’s FORWARD Stroke Study Brings Fresh Real World Data for Investors
Penumbra Inc. ($PEN) announced an update on their ongoing clinical study. Penum...
08-07 00:42
Penumbra Q2 EPS $0.88 Misses $1.20 Estimate, Sales $390.046M Beat $389.009M Estimate
Penumbra (NYSE:PEN) reported quarterly earnings of $0.88 per share which missed the analyst consensus estimate of $1.20 by 26.67 percent. This is a 23.48 percent decrease over earnings of $1.15 per share from the same period last year. The company reported quarterly sales of $390.046 million which b...
07-31 05:03
ClearBridge Small-Cap Growth Strategy adds new positions, exits others
ClearBridge Small-Cap Growth Strategy returned 21% in Q2 2026, underperforming the Russell 2000 Growth Index, which gained 26% during the same period. During Q2 2026, the strategy initiated 13 new pos...
07-20 22:08
Penumbra Initiates FORWARD Trial To Collect Safety, Efficacy Data On Mechanical Thrombectomy
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer assisted vacuum thrombecto...
07-07 21:11
美股大行评级 | 高盛上调AMD目标价从450美元升至640美元；伯恩斯坦上调阿斯麦目标价从1971美元升至2623美元
今日重点评级关注：Roth Capital：维持Nuvectis Pharma"买入"评级，目标价从20美元升至33美元；摩根士丹利：维持GXO Logistics"超配"评级，目标价从75美元升至78美元
07-07 11:34
